Although there are few studies in animal models and humans to indicate that ghrelin has any anti-inflammatory effect [66], progression of the low-grade inflammation in obesity might be accelerated by decrease in circulating levels of ghrelin and/or GHSR1a-mediated signalling in immune cells. Here, GHRL is linked to obesity due to melanocortin 4 receptor deficiency.